Tratamento de Linfomas Não-Hodgkin Agressivos com CHOP-BLEO: Estudo retrospectivo

Authors

  • Eduardo Carvalho Brandão Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • José Francisco Soares Departamento de Estatística. Universidade Federal de Minas Gerais (UFMG). Belo Horizonte (MG), Brasil
  • Eduardo Nascimento Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Eugénio Baumgratz Lopes Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • João Augusto M. Teixeira Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Maria do Carmo L. R. Vieira Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Maria Nunes Alvares Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Nedda Maria Vasconcelos Novaes Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Sebastião Cabral Filho Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Wagner Brant Moreira Serviço de Oncologia Clínica da Santa Casa de Misericórdia e Centro de Quimioterapia Antiblástica e imunoterapia do Hospital Belo Horizonte. Belo Horizonte (MG), Brasil

DOI:

https://doi.org/10.32635/2176-9745.RBC.1987v33n2.3198

Keywords:

Non-Hodgkin Lymphomas, Chemotherapy

Abstract

Agressive" non-Hodgkin lymphomas (146 cases) were studied in their response to Chop-Bleo therapy. There were 56.2% of complete remission in the 146 cases. Lmportant factors in prognosis included histologic data, presence of symptoms and clinical staging of the disease. Abdominal tumors (larger than 10cm in diameter) and presence of symptoms were influent on relapses. Five-year survival was 35% and four factors were influent in this aspect: age, previous treatments, presence of abdominal tumor, and, the most influent of all, complete remission. Toxicity was low, with only one death. Results are similar to those obtained by other medical centers.

Downloads

Download data is not yet available.

References

Grogan Ml, Jones SE - Atlas of the mmunologic, pathologic and clinical aspects of the malignant lymphomas. Tucson, University of Arizona Coliege of Medicine, 1984.

Rosemberg SA - Non-Hodkins iymphomas. in: Calabresi P. et al, medical oncology basic principies and clinicai management of cancer. New York, Macmiilan, 1985; 476-93.

Fisher RI, et aI. - Factors predicting iong-term survivai in diffuse mixed, histiocitic or undifferentiated iymphoma. Blood, 1981; 58:45-51. DOI: https://doi.org/10.1182/blood.V58.1.45.bloodjournal58145

Jagannath S, et al. - Stage iv diffuse iarge-cell lymphoma: a Iong-term analysis. Journal of Clinical Oncology, 1985; 3: 39-47. DOI: https://doi.org/10.1200/JCO.1985.3.1.39

Rodriguez V, et al. - Combination chemotherapy ("Chop-Bieo") in advanced (Non-Hodgkin) mahgnant iymp oma. Biood, 1977; 49:325-33. DOI: https://doi.org/10.1182/blood.V49.3.325.bloodjournal493325

Cochran WG - Statistical methods for strenghtening the common qui-quadrado tests. Biometrics, 10:417-51. DOI: https://doi.org/10.2307/3001616

Anderson 5, et al. - Statistical methods for comparativeStudies. New York, Wiley, 1980.

de Vita Jr V, Heliman 5 - Hodgkins disease and the non-Hodgkins Iymphoma. in: de Vita Jr VT e al. Cancer; principies |and|practice|of oncology. Philadelphia, J.B. Lippincott, 1982; 1926.

Jones ES, et al. - Chemotherapy with cyclophosphamide, doxorubicin, vincristine and prednisone alone or with ievamrsoie plus BCG for mahgnant Iymphoma: a Southwest Oncology Group Study. Journal of Clinical Oncology, 1985; 3: 1318-24. DOI: https://doi.org/10.1200/JCO.1985.3.10.1318

Lee R, et al. - A 10-year update of Chop-Bleo in the treatment of diffuse large-cell lymphoma. Journal of Clinical Oncology, 1986; 4: 1455-61. DOI: https://doi.org/10.1200/JCO.1986.4.10.1455

Herrmann R, et al. - The influence of histoiogic type on the Iymphomas. Cancer, 1982; 49: 314-22. DOI: https://doi.org/10.1002/1097-0142(19820115)49:2<314::AID-CNCR2820490218>3.0.CO;2-C

Fisher RI, et al - Diffuse agressive iymphomas increased survival after alternating flexible sequences of PROMACE and MOPP chemotherapy. Ann. int. Med., 1983, 98: 304-9. DOI: https://doi.org/10.7326/0003-4819-98-3-304

Lorico DL, de Vita Jr VT - Lymphomas. in: Pinedo HM, Charbner DA. Cancer chemotherapy 1983. Amsterdam, Eisevier, 1983; 248-81.

Gaynor ER, et al. - Treatment of diffuse histiocitic Iymphoma (DHL) With COMLA (Cyclophosphamide, Oncovin, Methotrexate, Leucovorin, Cytosine Arabinoside) a 10-Year experience in a single instituition. J. Chn Oncol., 1985; 3; 1596-604. DOI: https://doi.org/10.1200/JCO.1985.3.12.1596

Newcomer LN, et al. - Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with Ieucovor in rescue and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bieomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma. Cancer Treat. Rep., 1982; 66: 1279-84.

Klimo P, Connors JM - Macop-B chemotherapy for the treatment of diffuse large-cell Iymphoma. Ann. int. Med., 1985; 102 596-602. DOI: https://doi.org/10.7326/0003-4819-102-5-596

Coiffier B, et al. - Intensive and sequential com bination chemotherapy for aggressive malignant Iymphomas (Protocol LNH-80). J. Chn. Oncol., 1986; 4: 147-53. DOI: https://doi.org/10.1200/JCO.1986.4.2.147

Downloads

Published

2023-08-04

How to Cite

1.
Brandão EC, Soares JF, Nascimento E, Lopes EB, Teixeira JAM, Vieira M do CLR, Alvares MN, Novaes NMV, Cabral Filho S, Moreira WB. Tratamento de Linfomas Não-Hodgkin Agressivos com CHOP-BLEO: Estudo retrospectivo. Rev. Bras. Cancerol. [Internet]. 2023 Aug. 4 [cited 2024 May 20];33(2):141-9. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3198

Issue

Vol. 33 No. 2 (1987): June

Section

ORIGINAL ARTICLE

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)